Glycomimetics Inc

Ownership Transactions Reported by 17 Insiders

Symbol
GLYC on Nasdaq
Location
9708 Medical Center Drive, Rockville, Maryland

Insiders trading volume in the past year

Glycomimetics Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Scott D. Sandell 10%+ Owner $5.28M Jan 25, 2023
Siren, L.L.C. 10%+ Owner $2.29M Jul 25, 2024
Rachel K. King Director $1.55M May 1, 2024
Invus Public Equities, L.P. 10%+ Owner $1.21M -$489K -28.8% Aug 7, 2024
John L. Magnani SVP of Research, CSO $875K Nov 11, 2022
Chinmaya Rath SVP and Chief Business Officer $380K Jan 12, 2024
Bruce S. Johnson SVP & Chief Commercial Officer $328K Jan 12, 2024
Daniel M. Junius Director $295K May 1, 2024
Edwin Rock Chief Medical Officer $182K +$169K +1336% Jun 20, 2024
Patricia S. Andrews Director $138K May 1, 2024
Mark Alan Goldberg Director $109K May 1, 2024
Scott Koenig Director $86.7K May 1, 2024
Armand Girard SVP, Chief Business Officer $68.8K Nov 11, 2022
Brian M. Hahn SVP Finance, CFO $17.5K +$4.34K +32.9% Jun 18, 2024
Harout Semerjian Chief Executive Officer, Director Jan 12, 2024
Timothy R. Pearson Director May 1, 2024
Scott Thomas Jackson Director May 1, 2024

Recent Insider Transactions by Companies or Individuals for Glycomimetics Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.